The abstract is read at the publisher; the summary is JClub's.
In mouse primary hepatocytes, combined PFOA and HFPO-DA exposure produces non-additive lipidomic shifts, necroptosis activation, and Caspase-3/Caspase-9 upregulation versus single exposures.
- Why it matters: PFOA restriction led to HFPO-DA substitution, but its hepatic safety under realistic co-exposure with PFOA remains insufficiently validated, especially for PFAS mixtures.
- What they did: PBPK modeling predicted tissue accumulation, then primary hepatocytes were exposed to PFOA, HFPO-DA, or both, followed by lipidomic profiling, gene expression of insulin signaling and lipid/mitochondrial pathways, and immune/injury pathway readouts.
- The result: HFPO-DA alone drove stronger lipidomic perturbations, enhanced de novo lipogenesis, diacylglycerol accumulation, insulin signaling gene suppression, and Cers4/Cers6 upregulation, while co-exposure downregulated MG/DG/TG and activated necroptosis with increased Caspase-3 and Caspase-9, implying oxidation-dominated metabolism.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.